Literature DB >> 20739512

Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization.

Jennifer E Stevens-Lapsley1, Fan Ye, Min Liu, Stephen E Borst, Christine Conover, Kevin E Yarasheski, Glenn A Walter, H Lee Sweeney, Krista Vandenborne.   

Abstract

Insulin-like growth factor I (IGF-I) is a potent myogenic factor that plays a critical role in muscle regeneration and muscle hypertrophy. The purpose of this study was to evaluate the effect of IGF-I overexpression on the recovery of muscle size and function during reloading/reambulation after a period of cast immobilization in predominantly fast twitch muscles. In addition, we investigated concomitant molecular responses in IGF-I receptor and binding proteins (BPs). Recombinant adeno-associated virus vector for IGF-I (rAAV-IGF-IA) was injected into the anterior compartment of one of the hindlimbs of young (3 wk) C57BL6 female mice. At 20 wk of age, both hindlimbs were cast immobilized in a shortened position for 2 wk to unload the tibialis anterior (TA) and extensor longus digitorum (EDL) muscles. The TA and EDL muscles were removed bilaterally after 2 wk of cast immobilization and after 1 and 3 wk of free cage reambulation. Increases in IGF-I mRNA and protein levels with IGF-I overexpression were associated with significant increases in muscle wet weight, fiber size, and tetanic force, although overexpression did not protect against cast immobilization-induced muscle atrophy. After 1 wk of reambulation, evidence of enhanced muscle regeneration was noted in IGF-I-overexpressing muscles with an increased prevalence of central nuclei, embryonic myosin, and Pax7 positive fibers. We also observed larger relative gains in muscle size (wet weight and fiber area), but not force, during the 3-wk reambulation period in hindlimb muscles overexpressing IGF-I compared with contralateral control legs. Changes in IGFBP-5 mRNA expression during cast immobilization and reambulation paralleled those of IGF-I, whereas IGFBP-3 expression changed inversely to IGFBP-5.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739512      PMCID: PMC2980362          DOI: 10.1152/ajpendo.00230.2010

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  69 in total

Review 1.  Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation.

Authors:  Cunming Duan; Hongxia Ren; Shan Gao
Journal:  Gen Comp Endocrinol       Date:  2010-04-18       Impact factor: 2.822

2.  Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Counterpoint: IGF is not the major physiological regulator of muscle mass.

Authors:  Martin Flueck; Geoffrey Goldspink
Journal:  J Appl Physiol (1985)       Date:  2010-06

3.  Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle.

Authors:  E R Barton-Davis; D I Shoturma; H L Sweeney
Journal:  Acta Physiol Scand       Date:  1999-12

Review 4.  Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities.

Authors:  R C Baxter
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-06       Impact factor: 4.310

5.  Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation.

Authors:  Bert Blaauw; Marta Canato; Lisa Agatea; Luana Toniolo; Cristina Mammucari; Eva Masiero; Reimar Abraham; Marco Sandri; Stefano Schiaffino; Carlo Reggiani
Journal:  FASEB J       Date:  2009-08-06       Impact factor: 5.191

6.  Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle.

Authors:  B Awede; J Thissen; P Gailly; J Lebacq
Journal:  FEBS Lett       Date:  1999-11-19       Impact factor: 4.124

Review 7.  Changes in muscle mass with mechanical load: possible cellular mechanisms.

Authors:  Espen E Spangenburg
Journal:  Appl Physiol Nutr Metab       Date:  2009-06       Impact factor: 2.665

8.  Regulation of signaling pathways downstream of IGF-I/insulin by androgen in skeletal muscle of glucocorticoid-treated rats.

Authors:  Hui-Nan Yin; Jia-Ke Chai; Yong-Ming Yu; Chuan-An Shen; Yan-Qiu Wu; Yong-Ming Yao; Hui Liu; Li-Ming Liang; Ronald G Tompkins; Zhi-Yong Sheng
Journal:  J Trauma       Date:  2009-04

9.  Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles.

Authors:  H Schmalbruch; D M Lewis
Journal:  Muscle Nerve       Date:  2000-04       Impact factor: 3.217

10.  Interaction between satellite cells and skeletal muscle fibers.

Authors:  R Bischoff
Journal:  Development       Date:  1990-08       Impact factor: 6.868

View more
  23 in total

1.  Regenerative responses in slow- and fast-twitch muscles following moderate contusion spinal cord injury and locomotor training.

Authors:  Arun Jayaraman; Min Liu; Fan Ye; Glenn A Walter; Krista Vandenborne
Journal:  Eur J Appl Physiol       Date:  2012-05-29       Impact factor: 3.078

2.  Overexpression of insulin-like growth factor-1 attenuates skeletal muscle damage and accelerates muscle regeneration and functional recovery after disuse.

Authors:  Fan Ye; Sunita Mathur; Min Liu; Stephen E Borst; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Exp Physiol       Date:  2013-01-04       Impact factor: 2.969

Review 3.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

4.  Reduced skeletal muscle fiber size following caloric restriction is associated with calpain-mediated proteolysis and attenuation of IGF-1 signaling.

Authors:  Yue Lu; Jennifer S Bradley; Sarah R McCoski; John M Gonzalez; Alan D Ealy; Sally E Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-22       Impact factor: 3.619

5.  Hindlimb muscle morphology and function in a new atrophy model combining spinal cord injury and cast immobilization.

Authors:  Fan Ye; Celine Baligand; Jonathon E Keener; Ravneet Vohra; Wootaek Lim; Arjun Ruhella; Prodip Bose; Michael Daniels; Glenn A Walter; Floyd Thompson; Krista Vandenborne
Journal:  J Neurotrauma       Date:  2013-01-22       Impact factor: 5.269

6.  The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.

Authors:  Julia Durzyńska; Anastassios Philippou; Becky K Brisson; Michelle Nguyen-McCarty; Elisabeth R Barton
Journal:  Endocrinology       Date:  2013-02-13       Impact factor: 4.736

Review 7.  Optimizing IGF-I for skeletal muscle therapeutics.

Authors:  Anastassios Philippou; Elisabeth R Barton
Journal:  Growth Horm IGF Res       Date:  2014-06-19       Impact factor: 2.372

Review 8.  Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.

Authors:  Tadashi Yoshida; A Michael Tabony; Sarah Galvez; William E Mitch; Yusuke Higashi; Sergiy Sukhanov; Patrice Delafontaine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-13       Impact factor: 5.085

Review 9.  Role of IGF-I signaling in muscle bone interactions.

Authors:  Daniel D Bikle; Candice Tahimic; Wenhan Chang; Yongmei Wang; Anastassios Philippou; Elisabeth R Barton
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

10.  Muscle proteolytic system modulation through the effect of taurine on mice bearing muscular atrophy.

Authors:  Rania M Khalil; Walied S Abdo; Ahmed Saad; Eman G Khedr
Journal:  Mol Cell Biochem       Date:  2017-12-02       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.